Vimarsana
Biggest News Aggregation in the World

Biosimilar Basics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Biosimilar Basics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Biosimilar Basics Today - Breaking & Trending Today

Nonmedical Switch to Infliximab Biosimilar Safe, Linked to Cost Savings in Children with IBD - Vimarsana News

Nonmedical Switch to Infliximab Biosimilar Safe, Linked to Cost Savings in Children with IBD

Published: February 28, 2024

Inflammatory markers, infliximab levels, and physician global assessment scores remained similar when assessed pre- and post-switch to an infliximab biosimilar.

Source: hcplive.com
Related Topics:
Megan McnicolStakeholder Perspective To Improve Development Of DrugsDrug AdministrationNationwide ChildrenInflammatory Bowel Disease Clinic TeamPediatric GastroenterologyInflammatory Bowel DiseaseMulti Stakeholder PerspectiveImprove DevelopmentBiosimilar Basics
Biosimilars and Patients: Addressing Safety, Cost, Anxiety - Vimarsana News

Biosimilars and Patients: Addressing Safety, Cost, Anxiety

Published: March 30, 2023

Physicians can respond to pushback from patients on switching to a biosimilar by offering resources and discussing options for both biosimilar and reference drugs.

Source: medscape.com
Related Topics:
New YorkUnited StatesUniversity Of Rochester Medical CenterSameer AwsareVivek KaulKaiser PermanenteStephaniek FabbroMiguel RegueiroRobert PopovianPermanente Medical GroupOhio Medical University In RootstownCleveland Clinic Digestive Disease Surgery InstituteUniversity Of Nebraska Medical CenterDrug AdministrationColitis FoundationAccreditation Council For Medical AffairsBiosimilars Specialist ProgramGlobal Healthy Living FoundationCardinal HealthRheumatologist Marcus SnowNebraska Medical CenterAmerican CollegeOften DrivesGlobal Healthy LivingCleveland Clinic